
Julia Frede
@frede_julia
TT-Professor in Systems Immune Oncology | TUM | Interested in Cancer #Genomics, #Immunology and #SingleCell Biology.
ID: 2310294801
28-01-2014 18:17:19
146 Tweet
367 Followers
957 Following

Great talk by @TaylaForal on Combinatorial Effects of BH3 Mimetics and CAR T Cells Targeting T-Cell Lymphomas #ASH22 Dana-Farber


Great presentation by Prof. Haferlach on automated cell type classification in blood smears this morning #AI #ASH22 Munich Leukemia Laboratory


We are hiring a research technician to work on epithelial cell fate plasticity and early tumorigenesis at the Cambridge Stem Cell Institute. Last few days to apply!!! jobs.cam.ac.uk/job/39147/

Today is International Day of Women and Girls in Science! Congratulations to Dana-Farber's Laurie Glimcher, MD, Judy Garber, MD, Donna Neuberg, ScD, and Kornelia Polyak, MD, recognized among the best female scientists worldwide. #WomenInScience National Cancer Institute ➡️ ms.spr.ly/60145OUdQ


Babies born with brain tumors like GBM need better treatments. Check out talk today by Anne-Florence Blandin 🇪🇺🇫🇷 on ALK gliomas from LigonLab collaboration with Rameen Beroukhim @Bando_Lab ativsoftware.com/appinfo.php?pa… #AACR23







Excited to introduce scKINETICS, an algorithm for joint inference of gene regulatory mechanism and cellular velocity, co-developed by the amazing duo of Cassandra Burdziak and Julia Zhao academic.oup.com/bioinformatics…

👋 Hello 2024 - introducing nanoranger! 🐍 Are we ready to use Oxford Nanopore for tracking clonal evolution with #singlecell #genomics❓ Our manuscript provides vignettes on how, for example by tracking #AML during #immunotherapy 🔥🔥🔥 Nature Communications nature.com/articles/s4146… 👇1/


Currently at the inaugural two-day @dkfz junior group leader retreat, advancing #cancer research from discovery to therapy. A bright future awaits with highly motivated next-gen scientists at the helm. 🧬🔬 #CancerResearch #NewPI #InnovationInScience VomLaborInDiePraxis



Out now Blood Advances: "Dual role of signaling pathways in myeloma requires cell type–specific targeting of ligand-receptor interactions." ashpublications.org/bloodadvances/… #immunotherapy #immunobiology

Did you know that not all newly forming tumours persist long-term? If you are intrigued to know what determines the survival of early tumours, check out our latest preprint! Cambridge Stem Cell Institute, PDN Cambridge. Work led by Greta Skrupskelyte and @ lr 🧵1/8 biorxiv.org/cgi/content/sh…


Looking for a motivated and talented PhD student: Are you passionate about experimental/computational immunology and cancer biology? Join our team at TranslaTUM!🌟linkedin.com/jobs/view/4079… TU München TranslaTUM #PhDOpportunity #CancerResearch #Immunology #SystemsBiology